Paul Wicks

Paul Wicks

Company: Independent

Job title: Advocate


Panel Discussion: Promoting Earlier Commercial Discussions to Accelerate the Post-Approval Path to Market 9:00 am

What must be considered when deciphering commercially viable targets for ALS? How can we ensure access to promising, yet expensive, ALS treatments to patients who really need them? Why is it important to assess market viability during the early stages of initial R&D discussions?Read more

day: Day Two AM

Panel Discussion: Driving the Expansion of Comprehensive Genetic Testing to Expedite the Onset of Treatment for ALS Gene Carriers 4:30 pm

Highlighting the significant proportion of people at risk of genetic ALS and the urgency to streamline systematic genetic testing Addressing disparities in testing accessibility among different doctors, clinics, and health insurances Developing the framework for digital, cost-effective, and easily translatable platforms to monitor gene carriers over timeRead more

day: Day One PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.